Shang‐Fan Yu
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates(2012)980 cited
- → Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site(2009)363 cited
- → Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis(2003)283 cited
- → Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma(2009)264 cited
- → Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection(2009)248 cited
- → Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates(2014)200 cited
- → Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity(2019)185 cited
- → Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma(2007)169 cited
- → Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy(2021)161 cited
- → A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs(2015)159 cited